Patient with Arterial Hypertension at High Cardiovascular Risk: Focus on Telmisartan

Пристром, А.М.; Пристром, М.С.; Михно, М.М.; Рачок, С.М.; Казаков, С.А.; Пырочкин, А.В.; Зарадей, И.И.; Борисенко, Т.Д.

doi:10.34883/pi.2022.14.6.013

Кардиология В Беларуси

2023

DOI: 10.34883/pi.2022.14.6.013

|View full text |Cite

Patient with Arterial Hypertension at High Cardiovascular Risk: Focus on Telmisartan

А.М. Пристром¹,

М.С. Пристром²,

М.М. Михно³

et al.

Abstract: В статье рассматриваются современные возможности контроля артериального давления. Определена роль блокаторов рецепторов к ангиотензину II. Показаны преимущества телмисартана с точки зрения антигипертензивной эффективности и органопротекции. Также приводятся оригинальные данные клинического применения препарата Телмиста® (телмисартан) у пациентов с артериальной гипертензией. The article discusses modern opportunities of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 12 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Effect of Equamer on cardialgia and psychoautonomic status in woman with metabolically healthy obesity, estrogen deficiency, and hypertension in the late fertile period

Khabibulina,

Shamilov

2023

Vrach

View full text Add to dashboard Cite

A study group included 74 women with metabolically healthy obesity (MHO), estrogen-deficiency, and hypertension in the late fertile period (LFP); their mean age was 39.60±3.51 years) who was prescribed the antihypertensive agent Equamer as part of combination therapy. A control group consisted of 75 women with MHO in the LFP (their mean age was 39.50±3.49 years) with the normal level of estradiol and without hypertension. The study group was found to have an association of hypoestrogenism with psychoautonomic disorders, hypersymptopaticotonia, and cardialgia. After 6 months of therapy, the agent Equamer was shown to have a positive effect on the psychoautonomic status, the episodes of cardalgia in patients with estrogen-deficiency, MHO and hypertension in the LFP. Equamer has a high efficiency, is well tolerated by the patients (no adverse events were seen in the study), levels off the clinical manifestations of hypertension, normalizes blood pressure, lowers the body mass index, and exerts a complex harmonizing effect on a female organism.

show abstract

Effect of Equamer on cardialgia and psychoautonomic status in woman with metabolically healthy obesity, estrogen deficiency, and hypertension in the late fertile period

Khabibulina,

Shamilov

2023

Vrach

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Patient with Arterial Hypertension at High Cardiovascular Risk: Focus on Telmisartan

Cited by 1 publication

References 12 publications

Effect of Equamer on cardialgia and psychoautonomic status in woman with metabolically healthy obesity, estrogen deficiency, and hypertension in the late fertile period

Effect of Equamer on cardialgia and psychoautonomic status in woman with metabolically healthy obesity, estrogen deficiency, and hypertension in the late fertile period

Contact Info

Product

Resources

About